DIRECTOR, USAMRAA, 820 CHANDLER ST, FORT DETRICK MD 21702-5014

A -- PRECLINICAL PHARMACODYNAMICS AND PHARMACOKINETICS STUDIES OF INVESTIGATIONAL NEW DRUGS SOL DAMD17-97-R-0040 DUE 120897 POC Contract Specialist Juanita Bourne (301) 619-7426 Contracting Officer Patricia M. McAllister (301) 619-7360 (Site Code DAMD17) The U.S. Army Medical Research and Materiel Command (USAMRMC) has as one of its responsibilities the development of new drugs to protect or treat soldiers confronted with threats on the modern battlefield or exposed to endemic diseases during deployment. Preclinical pharmacodynamics and pharmacokinetics studies of investigational new drugs are needed in the early stage of drug development. The contract includes writing study protocols and conducting pharmacodynamics and pharmacokinetics studies of test articles. Protocols, studies, and reports shall be in compliance with the Food and Drug Administration guidelines and regulations and other applicable U.S. Government regulations. The contractor should be sufficiently flexible to study one candidate drug in two animal species simultaneously. The contractor must be able to respond rapidly to changing priorities. The Army expects to award a five year contract with work assigned through individual task orders. RFP DAMD17-97-R-0040 to be issued on/or about October 23, 1997. Only written requests will be (0267)

Loren Data Corp. http://www.ld.com (SYN# 0001 19970926\A-0001.SOL)